Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 30, 2023 - Issue 1
Submit an article Journal homepage
205
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Prevalence and Dose Dependency Analysis of Pentosan Polysulfate Sodium Maculopathy

Andrew M. Philipa Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USAView further author information
,
Kendall W. Wannamakera Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA;b Cincinnati Eye Institute, Cincinnati, Ohio, USACorrespondence[email protected]
View further author information
&
Daniel M. Millera Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA;b Cincinnati Eye Institute, Cincinnati, Ohio, USAView further author information
Pages 82-87 | Received 21 Jul 2021, Accepted 14 Jan 2022, Published online: 26 Jan 2022

References

  • Nickel JC, Moldwin R. FDA BRUDAC 2018 criteria for interstitial cystitis/bladder pain syndrome clinical trials: future direction for research. J Urol. 2018;200(1):39–42. doi:10.1016/j.juro.2018.02.011.
  • Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–544. doi:10.1016/j.juro.2011.03.132.
  • Elmiron [package insert]. ELMIRON ®-100 MG (PENTOSAN POLYSULFATE SODIUM) CAPSULES PRESCRIBING INFORMATION.; 2012.
  • Pearce WA, Chen R, Jain N. Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium. Ophthalmology. 2018;125(11):1793–1802. doi:10.1016/j.ophtha.2018.04.026.
  • Uner OE, Ward LT, Shah MK, and Jain N. Pentosan polysulfate maculopathy: findings from an international survey of exposed individuals. Investig Ophthalmol Vis Sci. 2020;61(7):1064. https://iovs.arvojournals.org/article.aspx?articleid=2769226 Accessed 21 June 2021.
  • Hanif AM, Shah R, Yan J, et al. Strength of association between Pentosan Polysulfate and a novel maculopathy. Ophthalmology. 2019;126(10):1464–1466. doi:10.1016/j.ophtha.2019.04.024.
  • Jain N, Li AL, Yu Y, Vanderbeek BL. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. Br J Ophthalmol. 2020;104(8):1093–1097. doi:10.1136/bjophthalmol-2019-314765.
  • Huckfeldt RM, Vavvas DG. Progressive maculopathy after discontinuation of pentosan polysulfate sodium. Ophthalmic Surg Lasers Imaging Retin. 2019;50(10):656–659. doi:10.3928/23258160-20191009-10.
  • Shah R, Simonett JM, Lyons RJ, Rao RC, Pennesi ME, Jain N. Pentosan polysulfate maculopathy: disease course after drug cessation. Investig Ophthalmol Vis Sci. 2020;138:894–900.
  • Hanif AM, Yan J, Jain N. Pattern dystrophy: an imprecise diagnosis in the age of precision medicine. Int Ophthalmol Clin. 2019;59(1):173–194. doi:10.1097/IIO.0000000000000262.
  • Hanif AM, Armenti ST, Taylor SC, et al. Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study. JAMA Ophthalmol. 2019;137(11):1275–1282. doi:10.1001/jamaophthalmol.2019.3392.
  • Clark SJ, Keenan TDL, Fielder HL, et al. Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera. Investig Ophthalmol Vis Sci. 2011;52(9):6511–6521. doi:10.1167/iovs.11-7909.
  • Greenlee T, Hom G, Conti T, et al. Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793-1802). Ophthalmology. 2019;126(7):e51. doi:10.1016/j.ophtha.2018.12.037.
  • Vora RA, Patel AP, Melles R. Prevalence of maculopathy associated with long-term pentosan polysulfate therapy. Ophthalmology. 2020;127(6):835–836. doi:10.1016/j.ophtha.2020.01.017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.